¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"smooth-rough variation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diurnal mood variation
    ÀÏÁß±âºÐº¯È­
  • diurnal variation
    ÇϷ纯ÀÌ, ÀÏÁߺ¯µ¿
  • ethnic variation
    ÀÎÁ¾°£º¯ÀÌ
  • genotypic variation
    À¯ÀüÀÚÇüº¯ÀÌ
  • individual variation
    °³Ã¼º¯ÀÌ
  • interindividual variation
    °³Àΰ£º¯ÀÌ
  • phenotypic variation
    Ç¥ÇöÇüº¯ÀÌ
  • seasonal variation
    °èÀýº¯ÀÌ
  • variation
    º¯ÀÌ
  • variation curve
    º¯À̰
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variation
    º¯ÀÌ
  • concomitant variation
    µ¿½Ãº¯ÀÌ
  • diurnal variation
    ÇϷ纯ÀÌ
  • ethnic variation
    ÀÎÁ¾°£º¯ÀÌ
  • genotypic variation
    À¯ÀüÀÚÇüº¯ÀÌ
  • individual variation
    °³Ã¼º¯ÀÌ
  • interindividual variation
    °³Àΰ£º¯ÀÌ
  • observer variation
    °üÂûÀÚº¯ÀÌ
  • phenotypic variation
    Ç¥ÇöÇüº¯ÀÌ
  • seasonal variation
    °èÀýº¯ÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variation curve
    º¯À̰
  • diurnal variation
    ÇϷ纯ÀÌ
  • dose rate variation
    ¼±·®·üº¯ÀÌ
  • ethnic variation
    ÀÎÁ¾°£º¯ÀÌ
  • genotypic variation
    À¯ÀüÀÚÇüº¯ÀÌ
  • individual variation
    °³Ã¼º¯ÀÌ
  • induced variation
    À¯µµº¯ÀÌ
  • interindividual variation
    °³Àΰ£º¯ÀÌ
  • intrapair variation
    ½ÖµÕÀ̰£º¯ÀÌ
  • observer variation
    °üÂûÀÚº¯ÀÌ
  • phase variation
    »óº¯ÀÌ
  • phenotypic variation
    Ç¥ÇöÇüº¯ÀÌ
  • sampling variation
    Ç¥º»º¯ÀÌ
  • seasonal variation
    °èÀýº¯ÀÌ
  • variation
    º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • S-R variation
    S-Rº¯ÀÌ
  • V-W variation
    V-Wº¯ÀÌ
  • annual variation
    ¿¬Â÷(Ëç̤), ¿¬º¯È­.
  • antigenic variation
    Ç׿øº¯ÀÌ(ù÷ê«Ü¨ì¶).
  • genetic variation
    À¯ÀüÀûº¯ÀÌ
  • genetic variation
    À¯Àüº¯ÀÌ(¡­Ü¨ì¶).
  • genotypic variation
    À¯ÀüÀÚÇüº¯µ¿.
  • genotypic variation
    À¯ÀüÀÚÇüº¯ÀÌ.
  • hereditable variation
    À¯Àü¼ºº¯ÀÌ
  • heritable variation
    À¯Àü¼º º¯ÀÌ.
  • inborn variation
    ¼±Ãµ¼º º¯ÀÌ.
  • individual variation
    °³Ã¼º¯ÀÌ.
  • induced variation
    À¯µµº¯ÀÌ.
  • phenotypic variation
    Ç¥Çöº¯ÀÌ(¡­Ü¨ì¶).
  • phenotypic variation
    Ç¥Çöº¯ÀÌ(¡­Ü¨ì¶).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • annual variation
    ¿¬Â÷(Ëç̤), ¿¬º¯È­.
  • antigen variation
    Ç׿øº¯ÀÌ.
  • antigenic variation
    Ç׿øº¯ÀÌ(ù÷ê«Ü¨ì¶).
  • bacterial variation
    ¼¼±Õº¯ÀÌ(á¬Ð¶Ü¨ì¶).
  • caliber variation
    ±¸°æº¯·®(ÊÙËÒËâ).
  • coefficient of variation
  • coefficint variation
    º¯À̰è¼ö
  • day-to-day variation
    ÀÏÀϺ¯µ¿Ä¡
  • diphasic variation
    ÀÌ»ó¼º º¯ÀÌ(¡­Ü¨ì¶).
  • diphasic variation
    ÀÌ»óº¯ÀÌ(¡­Ü¨ì¶).
  • diurnal variation
    ÀÏÂ÷º¯µ¿
  • diurnal variation =daily v.
    Àϳ»º¯µ¿(ìíҮܨÔÑ).
  • dose rate variation
    ¼±·®·ü º¯È­
  • double variation
    ÀÌÁߺ¯µ¿(ÊÙËÒËÄ).
  • erythrocyte variation
    ÀûÇ÷±¸º¯ÀÌ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Variation
    º¯ÀÌ
    [¿¾ ¿ë¾î] º¯ÀÌ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • smooth-rough variation
    ȰÁ¶ º¯ÀÌÁÖ(üÁðØÜ¨ì¶ñ»)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coefficient of variation
    ºÐ»ê°è¼ö(ÝÂߤÌõâ¦)
  • continuous variation
    ¿¬¼Óº¯ÀÌ(ææáÙܨì¶)
  • genotypic variation
    À¯ÀüÀÚÇü º¯µ¿(ë¶îîí­úþܨÔÑ)
  • method of continuous variation
    ¿¬¼Óº¯È­¹ý(Ö§áÙܨûùÛö)
  • phase variation
    »óº¯µ¿(ßÓܨÔÑ)
  • phenotypic variation
    Ç¥ÇöÇü º¯µ¿(øúúÞúþܨÔÑ)
  • rough-smooth variation
    Á¶È°(ðØüÁ) º¯ÀÌ(ܨì¶)
  • S -> R variation
    S ¡æR º¯µ¿(ܨÔÑ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interobserver variation
    °üÂûÀÚ°£º¯ÀÌ
  • magnetic susceptibility variation
    ÀÚ±âÈ­À²º¯ÀÌ
  • variation
    º¯ÀÌ, º¯µ¿
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CNV choroidal neovascularization; contingent negative variation; cutaneous necrotizing vasculitis
CV cardiac volume; cardiovascular; carotenoid vesicle; cell volume; central venous; cephalic vein; cere...
NV nausea and vomiting; negative variation; neovascularization; next visit; nonveteran; normal value; n...
PINV postimperative negative variation
TCNV terminal contingent negative variation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CV Coefficient of Variation
COV Coefficient of variation
CV coefficient variation
CNV Contingent Negative Variation
CFV cyclic flow variation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bacterial variation
    ¼¼±Õ º¯ÀÌ
    ¼¼±ÕÀÌ µ¿Á¤°ú ºÐÈ­¸¦ ÇÏ´Â µ¥ ¾²À̴ Ư¡ÀÇ ¹üÀ§.
  • caliber variation
    ±¸°æ º¯·®
  • carcadian variation
    ?
  • diurnal variation
    ÁÖ°£ º¯µ¿, ÀÏÁÖ º¯È­
  • dose rate variation
    ¼±·®·ü º¯È­
  • interobserver variation
    °üÂûÀÚ°£ º¯ÀÌ
  • magnetic susceptibility variation
    ÀÚ±âÈ­À² º¯ÀÌ
  • monophasic variation
    ´Ü»ó¼º º¯È­
  • severe variation
    ½ÉÇÑ º¯Çü
  • variation
    º¯ÀÌ, º¯µ¿, º¯Çü
    À¯ÀüÇÐÀûÀ¸·Î °³Ã¼¿¡ ¼ÓÇÏ´Â ±ºÀÇ Æ¯À¯ÇÑ Æ¯¼ºÀ¸·ÎºÎÅÍÀÇ ÆíÂ÷. ÀÚ¼ÕÀÇ Æ¯¼ºÀÌ ¾î¹öÀÌÀÇ Æ¯¼ºÀ¸·ÎºÎÅÍ º¯À§µÇ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
antigenic variation The phenomenon of changes in surface antigens in parasitic populations of Trypanosoma and Plasmodium (and some other parasitic protozoa) in order to escape immunological defense mechanisms. at least 100 different surface proteins have been found to appear and disappear during antigenic variation in a clone of trypanosomes. Each antigen is encoded in a separate gene. Antigenic variation is also known to occur in free living Protozoa and certain bacteria.
(18 Nov 1997)
variation In genetics, deviation in characters in an individual from those typical of the group to which it belongs, also, deviation in characters of the offspring from those of its parents.
(18 Nov 1997)
variation (genetics) The phenotypic differences among individuals in a population.
(12 Dec 1998)
phase variation <microbiology> Alteration in the expression of surface antigens by bacteria.
For example: Salmonella can express either of two forms of flagellin, H1 and H2, that are coded by different genes. Control of which form is expressed is brought about by inversion of the promoter for the H2 gene, which if functional (noninverted) is associated with the expression of H2 and the production of a repressor of the H1 gene.
Inversion occurs about every 1000 bacterial divisions and is under the control of another gene, hin, that is within the invertable sequence.
(31 Dec 1997)
coefficient of variation The ratio of the standard deviation to the mean.
(05 Mar 2000)
contingent negative variation An increasing negative shift of the cortical electrical potentials associated with an anticipated response to an expected stimulus. It is an electrical event indicative of a state of readiness or expectancy.
(12 Dec 1998)
somaclonal variation The variation between individuals in a clone, particularly in plant clones. While the objective is usually to grow clones without variation, somaclonal variation does provide the opportunity to generate new plant types that would be harder or impossible to generate by conventional plant breeding.
(14 Nov 1997)
isotypic variation <immunology> Variability of antigens common to all members of a species, for example the five classes of immunoglobulins found in humans.
See: idiotype and allotype.
(18 Nov 1997)
observer variation The failure by the observer to measure or identify a phenomenon accurately, which results in an error. Sources for this may be due to the observer's missing an abnormality, or to faulty technique resulting in incorrect test measurement, or to misinterpretation of the data. Two varieties are inter-observer variation (the amount observers vary from one another when reporting on the same material) and intra-observer variation (the amount one observer varies between observations when reporting more than once on the same material).
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variation
    º¯È­
  • grid variation
    ±×¸®µå ÆíÂ÷(ÁøÁ¤ ÀÚ¿À¼±°ú ÀÚ±â ÀÚ¿À¼±ÀÇ ±³°¢)
  • variation
    º¯È­;º¯µ¿;º¯È­·®(Á¤µµ);º¯È­¹°;º¯ÁÖ°î;º¯ÀÌ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á